Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
05
2022
accepted:
08
08
2022
entrez:
20
10
2022
pubmed:
21
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
The pathophysiology of COVID-19 remains poorly understood. We aimed to estimate the contribution of intrapulmonary shunting and ventilation-to-perfusion (VA/Q) mismatch using a mathematical model to construct oxygen-haemoglobin dissociation curves (ODCs). ODCs were constructed using transcutaneous pulse oximetry at two different fractions of inspired oxygen (FiO2). 199 patients were included from two large district general hospitals in the South East of England from 1st to 14th January 2021. The study was supported by the National Institute of Health Research (NIHR) Clinical Research Network. Overall mortality was 29%. Mean age was 68.2 years (SEM 1·2) with 46% female. Median shunt on admission was 17% (IQR 8-24.5); VA/Q was 0.61 (IQR 0.52-0.73). Shunt was 37.5% higher in deaths (median 22%, IQR 9-29) compared to survivors (16%, 8-21; p = 0.0088) and was a predictor of mortality (OR 1.04; 95% CI 1.01-1.07). Admission oxygen saturations were more strongly predictive of mortality (OR 0.91, 95% CI 0.87-0.96). There was no difference in VA/Q mismatch between deaths (0.60; IQR 0.50-0.73) and survivors (0.61; IQR 0.52-0.73; p = 0.63) and it was not predictive of mortality (OR 0.68; 95% CI 0.18-2.52; p = 0.55). Shunt negatively correlated with admission oxygen saturation (R -0.533; p<0.0001) whereas VA/Q was not (R 0.1137; p = 0.12). Shunt, not VA/Q mismatch, was associated with worsening hypoxia, though calculating shunt was not of prognostic value. This study adds to our understanding of the pathophysiology of hypoxaemia in COVID-19. Our inexpensive and reliable technique may provide further insights into the pathophysiology of hypoxia in other respiratory diseases.
Sections du résumé
BACKGROUND
The pathophysiology of COVID-19 remains poorly understood. We aimed to estimate the contribution of intrapulmonary shunting and ventilation-to-perfusion (VA/Q) mismatch using a mathematical model to construct oxygen-haemoglobin dissociation curves (ODCs).
METHODS
ODCs were constructed using transcutaneous pulse oximetry at two different fractions of inspired oxygen (FiO2). 199 patients were included from two large district general hospitals in the South East of England from 1st to 14th January 2021. The study was supported by the National Institute of Health Research (NIHR) Clinical Research Network.
RESULTS
Overall mortality was 29%. Mean age was 68.2 years (SEM 1·2) with 46% female. Median shunt on admission was 17% (IQR 8-24.5); VA/Q was 0.61 (IQR 0.52-0.73). Shunt was 37.5% higher in deaths (median 22%, IQR 9-29) compared to survivors (16%, 8-21; p = 0.0088) and was a predictor of mortality (OR 1.04; 95% CI 1.01-1.07). Admission oxygen saturations were more strongly predictive of mortality (OR 0.91, 95% CI 0.87-0.96). There was no difference in VA/Q mismatch between deaths (0.60; IQR 0.50-0.73) and survivors (0.61; IQR 0.52-0.73; p = 0.63) and it was not predictive of mortality (OR 0.68; 95% CI 0.18-2.52; p = 0.55). Shunt negatively correlated with admission oxygen saturation (R -0.533; p<0.0001) whereas VA/Q was not (R 0.1137; p = 0.12).
INTERPRETATION
Shunt, not VA/Q mismatch, was associated with worsening hypoxia, though calculating shunt was not of prognostic value. This study adds to our understanding of the pathophysiology of hypoxaemia in COVID-19. Our inexpensive and reliable technique may provide further insights into the pathophysiology of hypoxia in other respiratory diseases.
Identifiants
pubmed: 36264932
doi: 10.1371/journal.pone.0273402
pii: PONE-D-22-14285
pmc: PMC9584408
doi:
Substances chimiques
Oxygen
S88TT14065
Banques de données
figshare
['10.6084/m9.figshare.20553234.v1']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0273402Subventions
Organisme : Department of Health
Pays : United Kingdom
Déclaration de conflit d'intérêts
ASJC is an employee of Synoptic (funder). All other authors report no conflicts of interest.
Références
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Eur Respir J. 2021 Apr 22;57(4):
pubmed: 33303546
Physiol Rev. 2012 Jan;92(1):367-520
pubmed: 22298659
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Eur Respir J. 2021 Aug 12;58(2):
pubmed: 34210792
Lancet Respir Med. 2021 Jun;9(6):622-642
pubmed: 33965003
Respir Res. 2020 Jul 28;21(1):198
pubmed: 32723327
J Med Virol. 2021 Jan;93(1):573-575
pubmed: 32706407
Clin Med (Lond). 2020 Sep;20(5):e148-e153
pubmed: 32709637
Am J Respir Crit Care Med. 2020 Oct 1;202(7):1037-1039
pubmed: 32757969
World J Clin Cases. 2021 May 16;9(14):3385-3393
pubmed: 34002149
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
J Appl Physiol. 1960 May;15:405-10
pubmed: 13844133
Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6
pubmed: 32471783
J Am Coll Surg. 2020 Aug;231(2):281-288
pubmed: 32278725
J Clin Monit Comput. 2014 Dec;28(6):581-90
pubmed: 24402641
Acta Clin Belg. 2022 Apr;77(2):268-272
pubmed: 32966166
Front Cell Infect Microbiol. 2020 Jun 05;10:318
pubmed: 32582575
Eur Respir J. 2020 Oct 29;56(4):
pubmed: 32943402